Global Clinical Trials Support Service- Market
Global Clinical Trials Support Service- Market

Clinical Trials Support Service- Comprehensive Study by End-users (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Others), Indication (Inflammation, Oncology, Diabetes, Cardiovascular, Others), Service (Clinical Trial Site Management, Patient Recruitment Management, Data Management, Administrative Staff, IRB, Others) Players and Region - Global Market Outlook to 2026

Clinical Trials Support Service- Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2022 Edition 227 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Clinical Trials Support Service-?
Clinical Trial Support Services are distinct services provided by pharmaceutical businesses throughout the trial phase of new pharmaceuticals or the molecular analysis of generics and bio similar prior to their market release. These services are extremely useful in the event of a drug failure, assay design, and clinical testing. It also covers operations such as securing and storing research drugs, drug dose calculation, and kit handling.

The market study is broken down and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Clinical Trials Support Service- market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Charles River Laboratories (United States), IQVIA (United States), Pharmaceutical Product Development LLC (United States), WuXi AppTec (China), Parexel International (United States), Icon PLC (Ireland), Laboratory Corp. of America Holdings (United States), Novotech (Australia), PRA Health Sciences (United States) and Syneos Health (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Pharmaceutical Product Development (United States) and Medpace Holdings (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Clinical Trials Support Service- market by Type, Application and Region.

On the basis of geography, the market of Clinical Trials Support Service- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Pharmaceutical & Biopharmaceutical Companies will boost the Clinical Trials Support Service- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indication, the sub-segment i.e. Inflammation will boost the Clinical Trials Support Service- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service, the sub-segment i.e. Clinical Trial Site Management will boost the Clinical Trials Support Service- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
July 23, 2021 Eurofins Agroscience Services (EAS) announced that Pete Coody, Ph.D., and Martin Cole, Ph.D., are working in partnership with the EAS Hercules laboratory in North America to support the continued growth and development in our Environmental Disaster Assessment and Exercise System.



Market Trend
  • Growing Number of Investigative New Drugs

Market Drivers
  • Demand for Clinical Trials Support Service
  • Increasing Number of Prevalence of Diseases

Opportunities
  • Technological Up gradation owing to continuous R&D

Restraints
  • Stringent Regulations for Patient Enrollment
  • Inadequate Frameworks for Handling Trials

Challenges
  • Lack of Skilled Workforce


Key Target Audience
Medical Device Companies, Clinical Research Organizations, Healthcare Providers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Charles River Laboratories (United States), IQVIA (United States), Pharmaceutical Product Development LLC (United States), WuXi AppTec (China), Parexel International (United States), Icon PLC (Ireland), Laboratory Corp. of America Holdings (United States), Novotech (Australia), PRA Health Sciences (United States) and Syneos Health (United States) etc.

2. Can we have customized study for Clinical Trials Support Service- Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Clinical Trials Support Service- Market by 2026?
Analysts at AMA estimates Clinical Trials Support Service- Market to reach USD Million by 2026.
Report Objectives / Segmentation Covered
By End-users
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others

By Indication
  • Inflammation
  • Oncology
  • Diabetes
  • Cardiovascular
  • Others

By Service
  • Clinical Trial Site Management
  • Patient Recruitment Management
  • Data Management
  • Administrative Staff
  • IRB
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Demand for Clinical Trials Support Service
      • 3.2.2. Increasing Number of Prevalence of Diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Workforce
    • 3.4. Market Trends
      • 3.4.1. Growing Number of Investigative New Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Trials Support Service-, by End-users, Indication, Service and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Clinical Trials Support Service- (Value)
      • 5.2.1. Global Clinical Trials Support Service- by: End-users (Value)
        • 5.2.1.1. Pharmaceutical & Biopharmaceutical Companies
        • 5.2.1.2. Medical Device Companies
        • 5.2.1.3. Others
      • 5.2.2. Global Clinical Trials Support Service- by: Indication (Value)
        • 5.2.2.1. Inflammation
        • 5.2.2.2. Oncology
        • 5.2.2.3. Diabetes
        • 5.2.2.4. Cardiovascular
        • 5.2.2.5. Others
      • 5.2.3. Global Clinical Trials Support Service- by: Service (Value)
        • 5.2.3.1. Clinical Trial Site Management
        • 5.2.3.2. Patient Recruitment Management
        • 5.2.3.3. Data Management
        • 5.2.3.4. Administrative Staff
        • 5.2.3.5. IRB
        • 5.2.3.6. Others
      • 5.2.4. Global Clinical Trials Support Service- Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Clinical Trials Support Service-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Charles River Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IQVIA (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pharmaceutical Product Development LLC (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. WuXi AppTec (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Parexel International (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Icon PLC (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Laboratory Corp. of America Holdings (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novotech (Australia)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. PRA Health Sciences (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Syneos Health (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Clinical Trials Support Service- Sale, by End-users, Indication, Service and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Clinical Trials Support Service- (Value)
      • 7.2.1. Global Clinical Trials Support Service- by: End-users (Value)
        • 7.2.1.1. Pharmaceutical & Biopharmaceutical Companies
        • 7.2.1.2. Medical Device Companies
        • 7.2.1.3. Others
      • 7.2.2. Global Clinical Trials Support Service- by: Indication (Value)
        • 7.2.2.1. Inflammation
        • 7.2.2.2. Oncology
        • 7.2.2.3. Diabetes
        • 7.2.2.4. Cardiovascular
        • 7.2.2.5. Others
      • 7.2.3. Global Clinical Trials Support Service- by: Service (Value)
        • 7.2.3.1. Clinical Trial Site Management
        • 7.2.3.2. Patient Recruitment Management
        • 7.2.3.3. Data Management
        • 7.2.3.4. Administrative Staff
        • 7.2.3.5. IRB
        • 7.2.3.6. Others
      • 7.2.4. Global Clinical Trials Support Service- Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Trials Support Service-: by End-users(USD Million)
  • Table 2. Clinical Trials Support Service- Pharmaceutical & Biopharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 3. Clinical Trials Support Service- Medical Device Companies , by Region USD Million (2015-2020)
  • Table 4. Clinical Trials Support Service- Others , by Region USD Million (2015-2020)
  • Table 5. Clinical Trials Support Service-: by Indication(USD Million)
  • Table 6. Clinical Trials Support Service- Inflammation , by Region USD Million (2015-2020)
  • Table 7. Clinical Trials Support Service- Oncology , by Region USD Million (2015-2020)
  • Table 8. Clinical Trials Support Service- Diabetes , by Region USD Million (2015-2020)
  • Table 9. Clinical Trials Support Service- Cardiovascular , by Region USD Million (2015-2020)
  • Table 10. Clinical Trials Support Service- Others , by Region USD Million (2015-2020)
  • Table 11. Clinical Trials Support Service-: by Service(USD Million)
  • Table 12. Clinical Trials Support Service- Clinical Trial Site Management , by Region USD Million (2015-2020)
  • Table 13. Clinical Trials Support Service- Patient Recruitment Management , by Region USD Million (2015-2020)
  • Table 14. Clinical Trials Support Service- Data Management , by Region USD Million (2015-2020)
  • Table 15. Clinical Trials Support Service- Administrative Staff , by Region USD Million (2015-2020)
  • Table 16. Clinical Trials Support Service- IRB , by Region USD Million (2015-2020)
  • Table 17. Clinical Trials Support Service- Others , by Region USD Million (2015-2020)
  • Table 18. South America Clinical Trials Support Service-, by Country USD Million (2015-2020)
  • Table 19. South America Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 20. South America Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 21. South America Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 22. Brazil Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 23. Brazil Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 24. Brazil Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 25. Argentina Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 26. Argentina Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 27. Argentina Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 28. Rest of South America Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 29. Rest of South America Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 30. Rest of South America Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 31. Asia Pacific Clinical Trials Support Service-, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 33. Asia Pacific Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 34. Asia Pacific Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 35. China Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 36. China Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 37. China Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 38. Japan Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 39. Japan Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 40. Japan Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 41. India Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 42. India Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 43. India Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 44. South Korea Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 45. South Korea Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 46. South Korea Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 47. Taiwan Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 48. Taiwan Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 49. Taiwan Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 50. Australia Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 51. Australia Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 52. Australia Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 56. Europe Clinical Trials Support Service-, by Country USD Million (2015-2020)
  • Table 57. Europe Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 58. Europe Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 59. Europe Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 60. Germany Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 61. Germany Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 62. Germany Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 63. France Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 64. France Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 65. France Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 66. Italy Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 67. Italy Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 68. Italy Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 69. United Kingdom Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 70. United Kingdom Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 71. United Kingdom Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 72. Netherlands Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 73. Netherlands Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 74. Netherlands Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 75. Rest of Europe Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 76. Rest of Europe Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 77. Rest of Europe Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 78. MEA Clinical Trials Support Service-, by Country USD Million (2015-2020)
  • Table 79. MEA Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 80. MEA Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 81. MEA Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 82. Middle East Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 83. Middle East Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 84. Middle East Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 85. Africa Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 86. Africa Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 87. Africa Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 88. North America Clinical Trials Support Service-, by Country USD Million (2015-2020)
  • Table 89. North America Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 90. North America Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 91. North America Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 92. United States Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 93. United States Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 94. United States Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 95. Canada Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 96. Canada Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 97. Canada Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 98. Mexico Clinical Trials Support Service-, by End-users USD Million (2015-2020)
  • Table 99. Mexico Clinical Trials Support Service-, by Indication USD Million (2015-2020)
  • Table 100. Mexico Clinical Trials Support Service-, by Service USD Million (2015-2020)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Clinical Trials Support Service-: by End-users(USD Million)
  • Table 112. Clinical Trials Support Service- Pharmaceutical & Biopharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 113. Clinical Trials Support Service- Medical Device Companies , by Region USD Million (2021-2026)
  • Table 114. Clinical Trials Support Service- Others , by Region USD Million (2021-2026)
  • Table 115. Clinical Trials Support Service-: by Indication(USD Million)
  • Table 116. Clinical Trials Support Service- Inflammation , by Region USD Million (2021-2026)
  • Table 117. Clinical Trials Support Service- Oncology , by Region USD Million (2021-2026)
  • Table 118. Clinical Trials Support Service- Diabetes , by Region USD Million (2021-2026)
  • Table 119. Clinical Trials Support Service- Cardiovascular , by Region USD Million (2021-2026)
  • Table 120. Clinical Trials Support Service- Others , by Region USD Million (2021-2026)
  • Table 121. Clinical Trials Support Service-: by Service(USD Million)
  • Table 122. Clinical Trials Support Service- Clinical Trial Site Management , by Region USD Million (2021-2026)
  • Table 123. Clinical Trials Support Service- Patient Recruitment Management , by Region USD Million (2021-2026)
  • Table 124. Clinical Trials Support Service- Data Management , by Region USD Million (2021-2026)
  • Table 125. Clinical Trials Support Service- Administrative Staff , by Region USD Million (2021-2026)
  • Table 126. Clinical Trials Support Service- IRB , by Region USD Million (2021-2026)
  • Table 127. Clinical Trials Support Service- Others , by Region USD Million (2021-2026)
  • Table 128. South America Clinical Trials Support Service-, by Country USD Million (2021-2026)
  • Table 129. South America Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 130. South America Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 131. South America Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 132. Brazil Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 133. Brazil Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 134. Brazil Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 135. Argentina Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 136. Argentina Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 137. Argentina Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 138. Rest of South America Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 139. Rest of South America Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 140. Rest of South America Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 141. Asia Pacific Clinical Trials Support Service-, by Country USD Million (2021-2026)
  • Table 142. Asia Pacific Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 143. Asia Pacific Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 144. Asia Pacific Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 145. China Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 146. China Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 147. China Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 148. Japan Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 149. Japan Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 150. Japan Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 151. India Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 152. India Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 153. India Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 154. South Korea Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 155. South Korea Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 156. South Korea Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 157. Taiwan Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 158. Taiwan Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 159. Taiwan Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 160. Australia Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 161. Australia Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 162. Australia Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 166. Europe Clinical Trials Support Service-, by Country USD Million (2021-2026)
  • Table 167. Europe Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 168. Europe Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 169. Europe Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 170. Germany Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 171. Germany Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 172. Germany Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 173. France Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 174. France Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 175. France Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 176. Italy Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 177. Italy Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 178. Italy Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 179. United Kingdom Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 180. United Kingdom Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 181. United Kingdom Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 182. Netherlands Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 183. Netherlands Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 184. Netherlands Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 185. Rest of Europe Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 186. Rest of Europe Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 187. Rest of Europe Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 188. MEA Clinical Trials Support Service-, by Country USD Million (2021-2026)
  • Table 189. MEA Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 190. MEA Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 191. MEA Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 192. Middle East Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 193. Middle East Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 194. Middle East Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 195. Africa Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 196. Africa Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 197. Africa Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 198. North America Clinical Trials Support Service-, by Country USD Million (2021-2026)
  • Table 199. North America Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 200. North America Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 201. North America Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 202. United States Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 203. United States Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 204. United States Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 205. Canada Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 206. Canada Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 207. Canada Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 208. Mexico Clinical Trials Support Service-, by End-users USD Million (2021-2026)
  • Table 209. Mexico Clinical Trials Support Service-, by Indication USD Million (2021-2026)
  • Table 210. Mexico Clinical Trials Support Service-, by Service USD Million (2021-2026)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Trials Support Service-: by End-users USD Million (2015-2020)
  • Figure 5. Global Clinical Trials Support Service-: by Indication USD Million (2015-2020)
  • Figure 6. Global Clinical Trials Support Service-: by Service USD Million (2015-2020)
  • Figure 7. South America Clinical Trials Support Service- Share (%), by Country
  • Figure 8. Asia Pacific Clinical Trials Support Service- Share (%), by Country
  • Figure 9. Europe Clinical Trials Support Service- Share (%), by Country
  • Figure 10. MEA Clinical Trials Support Service- Share (%), by Country
  • Figure 11. North America Clinical Trials Support Service- Share (%), by Country
  • Figure 12. Global Clinical Trials Support Service- share by Players 2020 (%)
  • Figure 13. Global Clinical Trials Support Service- share by Players (Top 3) 2020(%)
  • Figure 14. Global Clinical Trials Support Service- share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Charles River Laboratories (United States) Revenue: by Geography 2020
  • Figure 18. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 19. IQVIA (United States) Revenue: by Geography 2020
  • Figure 20. Pharmaceutical Product Development LLC (United States) Revenue, Net Income and Gross profit
  • Figure 21. Pharmaceutical Product Development LLC (United States) Revenue: by Geography 2020
  • Figure 22. WuXi AppTec (China) Revenue, Net Income and Gross profit
  • Figure 23. WuXi AppTec (China) Revenue: by Geography 2020
  • Figure 24. Parexel International (United States) Revenue, Net Income and Gross profit
  • Figure 25. Parexel International (United States) Revenue: by Geography 2020
  • Figure 26. Icon PLC (Ireland) Revenue, Net Income and Gross profit
  • Figure 27. Icon PLC (Ireland) Revenue: by Geography 2020
  • Figure 28. Laboratory Corp. of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 29. Laboratory Corp. of America Holdings (United States) Revenue: by Geography 2020
  • Figure 30. Novotech (Australia) Revenue, Net Income and Gross profit
  • Figure 31. Novotech (Australia) Revenue: by Geography 2020
  • Figure 32. PRA Health Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 33. PRA Health Sciences (United States) Revenue: by Geography 2020
  • Figure 34. Syneos Health (United States) Revenue, Net Income and Gross profit
  • Figure 35. Syneos Health (United States) Revenue: by Geography 2020
  • Figure 36. Global Clinical Trials Support Service-: by End-users USD Million (2021-2026)
  • Figure 37. Global Clinical Trials Support Service-: by Indication USD Million (2021-2026)
  • Figure 38. Global Clinical Trials Support Service-: by Service USD Million (2021-2026)
  • Figure 39. South America Clinical Trials Support Service- Share (%), by Country
  • Figure 40. Asia Pacific Clinical Trials Support Service- Share (%), by Country
  • Figure 41. Europe Clinical Trials Support Service- Share (%), by Country
  • Figure 42. MEA Clinical Trials Support Service- Share (%), by Country
  • Figure 43. North America Clinical Trials Support Service- Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Charles River Laboratories (United States)
  • IQVIA (United States)
  • Pharmaceutical Product Development LLC (United States)
  • WuXi AppTec (China)
  • Parexel International (United States)
  • Icon PLC (Ireland)
  • Laboratory Corp. of America Holdings (United States)
  • Novotech (Australia)
  • PRA Health Sciences (United States)
  • Syneos Health (United States)
Additional players considered in the study are as follows:
Pharmaceutical Product Development (United States) , Medpace Holdings (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation